rs921083171
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_000245.4(MET):c.682T>A(p.Phe228Ile) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F228L) has been classified as Uncertain significance.
Frequency
 Genomes: not found (cov: 32) 
Consequence
 MET
NM_000245.4 missense
NM_000245.4 missense
Scores
 3
 10
 6
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  4.84  
Publications
0 publications found 
Genes affected
 MET  (HGNC:7029):  (MET proto-oncogene, receptor tyrosine kinase) This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers. [provided by RefSeq, May 2016] 
 COMETT  (HGNC:51196):  (cytosolic oncogenic antisense to MET transcript) This gene encodes a natural antisense transcript highly expressed in papillary thyroid carcinomas harboring BRAF V600E mutation or RET gene rearrangements. This lncRNA induces the downstream MAPK pathway and is part of a co-expression network including different oncogenes belonging to the MAPK and PI3H/AKT pathways. In thyroid carcinomas, this gene has oncogenic properties associated with increased proliferation and drug resistance. [provided by RefSeq, Jan 2020] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| MET | NM_000245.4 | c.682T>A | p.Phe228Ile | missense_variant | Exon 2 of 21 | ENST00000397752.8 | NP_000236.2 | 
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
32
GnomAD4 exome Cov.: 32 
GnomAD4 exome 
Cov.: 
32
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
32
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Pathogenic 
 BayesDel_addAF 
 Uncertain 
T 
 BayesDel_noAF 
 Benign 
 DANN 
 Uncertain 
 DEOGEN2 
 Benign 
T;.;. 
 Eigen 
 Pathogenic 
 Eigen_PC 
 Pathogenic 
 FATHMM_MKL 
 Uncertain 
D 
 LIST_S2 
 Uncertain 
D;D;D 
 M_CAP 
 Benign 
T 
 MetaRNN 
 Uncertain 
D;D;D 
 MetaSVM 
 Benign 
T 
 MutationAssessor 
 Uncertain 
M;M;M 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Benign 
N;N;N 
 REVEL 
 Uncertain 
 Sift 
 Uncertain 
D;D;D 
 Sift4G 
 Uncertain 
D;D;D 
 Polyphen 
D;D;. 
 Vest4 
 MutPred 
Gain of ubiquitination at K223 (P = 0.1797);Gain of ubiquitination at K223 (P = 0.1797);Gain of ubiquitination at K223 (P = 0.1797);
 MVP 
 MPC 
 1.1 
 ClinPred 
D 
 GERP RS 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.